Selective serotonin re-uptake inhibitors A review of the side effects in adolescents

被引：0
作者：
Gordon, Michael [1 ,2 ]
Melvin, Glenn [3 ]
机构：
[1] Monash Hlth Early Life, Unit Head Early Life, Clayton, Vic, Australia
[2] Monash Univ, Melbourne, Vic 3004, Australia
[3] Monash Univ, Ctr Dev Psychiat & Psychol, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia
来源：
AUSTRALIAN FAMILY PHYSICIAN | 2013年 / 42卷 / 09期
关键词：
adolescent psychiatry; selective serotonin re-uptake inhibitors; adolescent; adverse drug events; mental health; COGNITIVE-BEHAVIORAL THERAPY; MAJOR DEPRESSIVE DISORDER; ANTIDEPRESSANT TREATMENT; DISCONTINUATION SYNDROME; SEXUAL DYSFUNCTION; SUICIDE; CHILDREN; RISK; FLUOXETINE; SERTRALINE;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Background Selective serotonin re-uptake inhibitors (SSRIs) are prescribed by general practitioners (GPs) for adolescents. GPs' prescribing patterns for SSRIs changed following warnings issued by United Kingdom and United States drug advisory bodies on the use of antidepressants in children and adolescents in 2003 and 2004, respectively. Recent studies shed further light on the safety profile of SSRIs with adolescents. Objective To provide a narrative review of the physical and psychiatric side effects of SSRIs as reported by adolescents. To provide GPs with practical advice regarding the prevalence and nature of side effects of SSRIs when prescribed for adolescents. Discussion The research literature Suggests that adolescents taking SSRIs are at a small, but increased, risk of suicidal thoughts and behaviours. The prescribing GP needs to be aware of a number of potential side effects and interactions. Monitoring for common physical side effects and possible emerging suicidal ideas and behaviours, especially early in treatment, is recommended.
引用
收藏
页码：620 / 623
页数：4
相关论文
共 43 条
[1]   Suicidal risk in antidepressant drug trials [J].
Baldessarini, RJ ;
Pompili, M ;
Tondo, L .
ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (03) :246-248
[2]  
Black K, 2000, J PSYCHIATR NEUROSCI, V25, P255
[3]   The serotonin syndrome [J].
Boyer, EW ;
Shannon, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1112-1120
[4]   Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment - A meta-analysis of randomized controlled trials [J].
Bridge, Jeffrey A. ;
Iyengar, Satish ;
Salary, Cheryl B. ;
Barbe, Remy P. ;
Birmaher, Boris ;
Pincus, Harold Alan ;
Ren, Lulu ;
Brent, David A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (15) :1683-1696
[5]   Review of the efficacy and safety of antidepressants in youth depression [J].
Cheung, AH ;
Emslie, GJ ;
Mayes, TL .
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2005, 46 (07) :735-754
[6]   Selective serotonin reuptake inhibitor discontinuation syndrome in children: Six case reports [J].
Diler, RS ;
Avci, A .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2002, 63 (03) :188-197
[7]   Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists [J].
Efron, D ;
Hiscock, H ;
Sewell, JR ;
Cranswick, NE ;
Vance, ALA ;
Tyl, Y ;
Luk, ESL .
PEDIATRICS, 2003, 111 (02) :372-375
[8]   Treatment for Adolescents with Depression Study (TADS): Safety results [J].
Emslie, Graham ;
Kratochvil, Christopher ;
Vitiello, Benedetto ;
Silva, Susan ;
Mayes, Taryn ;
McNulty, Steven ;
Weller, Elizabeth ;
Waslick, Bruce ;
Casat, Charles ;
Walkup, John ;
Pathak, Sanjeev ;
Rohde, Paul ;
Posner, Kelly ;
March, John .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (12) :1440-1455
[9]  
*FDA, 2004, LAB CHANG REQ LETT A
[10]  
Ghanizadeh A, 2008, PSYCHOPHARMACOL BULL, V41, P76
12345